This article examines a number of different disease-modifying therapy strategies for the treatment of relapsing-remitting multiple sclerosis.
This review provides a comprehensive overview of miRNAs as biomarkers and therapeutic targets for neurodegenerative disorders.
In circadian rhythm sleep–wake disorders precision medicine is less developed than in other medical disciplines mainly because homeostatic sleep and circadian timing have a very complex phenotype with multiple genetic regulation mechanisms.
Dr Coffman is currently studying the mechanisms by which chronic early-life stress increases adult disease risk, using zebrafish as a model organism to ask how such stress affects immune system development and regulation.
With catalogued genetic variants, prospective genotyping of athletes at the beginning of their career could allow medical professionals to improve concussion management and return-to-play decisions.
Karmakar & Reilly review what is known about the role of NF1 mutation in immune cell function & the role of immune cells in promoting tumorigenesis in NF1.
In this editorial, the authors discuss how emerging technologies could provide an answer to remaining questions in concussion, including identification and return-to-play protocol standards.
In this commentary, Turo Nurmikko focuses on the choice of surgical treatment in an unoperated patient with clinically established trigeminal neuralgia.
In the quest to cross the BBB, researchers have developed immunoliposomes targeted to BBB receptors and α-synuclein that could potentially enable the transport of drugs to reach one of the drug targets in Parkinson’s disease.